Literature DB >> 33738051

Androgen Receptor Protein Degradation in the Treatment of Castration-Resistant Prostate Cancer.

Robert B Kargbo1.   

Abstract

Entities:  

Year:  2021        PMID： 33738051      PMCID： PMC7957932          DOI： 10.1021/acsmedchemlett.1c00059

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  5 in total

Review 1.  Advances in the computational development of androgen receptor antagonists.

Authors:  Xueping Hu; Xin Chai; Xuwen Wang; Mojie Duan; Jinping Pang; Weitao Fu; Dan Li; Tingjun Hou
Journal:  Drug Discov Today       Date:  2020-05-18       Impact factor: 7.851

Review 2.  Anti-androgen hormonal therapy for cancer and other diseases.

Authors:  Sebastian Student; Tomasz Hejmo; Aleksandra Poterała-Hejmo; Aleksandra Leśniak; Rafał Bułdak
Journal:  Eur J Pharmacol       Date:  2019-11-08       Impact factor: 4.432

3.  A critical update on the strategies towards modulators targeting androgen receptors.

Authors:  Hongyu Luan; Pengfei Xu; Ying Meng; Zhiyu Li; Jinlei Bian
Journal:  Bioorg Med Chem       Date:  2020-05-12       Impact factor: 3.641

Review 4.  Discovery of drugs that directly target the intrinsically disordered region of the androgen receptor.

Authors:  Marianne D Sadar
Journal:  Expert Opin Drug Discov       Date:  2020-02-26       Impact factor: 6.098

Review 5.  A review of prostate cancer treatment impact on the CNS and cognitive function.

Authors:  Charles Ryan; Jeffrey S Wefel; Alicia K Morgans
Journal:  Prostate Cancer Prostatic Dis       Date:  2019-12-16       Impact factor: 5.554
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.